Age group | Number of admissions in the rare disease population (% of the total rare disease population) | Number of admissions in the general population (% of the total general population, including all diseases) |
---|---|---|
0–4 | 97,416 (17.8%) | 1,373,714 (8.0%) |
5–9 | 34,438 (6.3%) | 259,111 (1.5%) |
10–14 | 26,776 (4.9%) | 208,713 (1.2%) |
15–19 | 28,565(5.2%) | 256,811 (1.5%) |
20–24 | 26,808 (4.9%) | 369,707 (2.2%) |
25–29 | 27,598 (5.0%) | 597,883 (3.5%) |
30–34 | 28,001 (5.1%) | 824,150 (4.8%) |
35–39 | 21,554 (3.9%) | 768,238 (4.5%) |
40–44 | 17,983 (3.3%) | 709,462 (4.2%) |
45–49 | 21,336 (3.9%) | 914,342 (5.3%) |
50–54 | 28,092 (5.1%) | 1,161,757 (6.8%) |
55–59 | 30,965 (5.7%) | 1,284,643 (7.5%) |
60–64 | 30,686 (5.6%) | 1,273,321 (7.5%) |
65–69 | 28,174 (5.2%) | 1,238,402 (7.2%) |
70–74 | 25,249 (4.6%) | 1,298,569 (7.6%) |
75–79 | 27,861 (5.1%) | 1,494,884 (8.7%) |
80–84 | 23,493 (4.3%) | 1,397,762 (8.2%) |
85+ | 21,678 (4.0%) | 1,659,092 (9.7%) |
Total | 546,673 | 17,090,561 |